等待开盘 10-22 09:30:00 美东时间
-0.120
-4.82%
今日重点评级关注:Maxim Group:维持Rani Therapeutics Hldgs"买入"评级,目标价从5美元升至10美元;韦德布什:维持Corbus Pharmaceuticals"跑赢大市"评级,目标价从31美元升至38美元
10-21 18:13
Collplant Holdings ( ($CLGN) ) has issued an announcement. On October 20, 2025,...
10-21 02:29
D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price target.
10-20 21:27
The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research.According to a scientific article published in the Archives of Dermatological Research, the model developed by
10-16 19:07
Gainers SciSparc (NASDAQ:SPRC) stock increased by 40.8% to $6.28 during Tuesda...
09-30 20:09
CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trialsREHOVOT, Israel, Sept. 30, 2025 /PRNewswire/ -- CollPlant Biotechnologies
09-30 19:04
REHOVOT, Israel, Sept. 15, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies an...
09-15 19:00
Collplant Holdings ( ($CLGN) ) has provided an update. CollPlant Biotechnologie...
09-13 04:51
In the last three months, 4 analysts have published ratings on CollPlant Biotec...
08-21 21:01
CollPlant Biotechnologies shares are trading lower after the company reported w...
08-20 23:49